Supplied ready-to-use with a simple usage protocol, STEM CELLBANKER is completely free of serum and animal derived components, and contains only Japanese, European or US Pharmacopoeia graded ingredients. STEM CELLBANKER significantly increases cell viability while maintaining cell pluripotency, normal karyotype and proliferation ability following resuscitation from cryopreservation, even after extended long-term storage. Independent research has demonstrated that hESC, MSCs and iPS cells cryopreserved with STEM CELLBANKER produce significantly higher cell viability (> 90%) over conventional freezing medium, while retaining cell pluripotency, normal karyotype and proliferation ability. Every batch of STEM CELLBANKER cryopreservation medium is performance tested on Jurkat and SK-007 cells. Additional standard evaluations for endotoxins, pH, osmolarity and Mycoplasma contaminants are undertaken to ensure GMP equivalent quality.
The study, published in a special issue of Cell Medicine, can be viewed at http://www.ingentaconnect.com/content/cog/cm/2012/00000003/F0030001/art00012. For further information on STEM CELLBANKER please visit www.amsbio.com/STEM-CELLBANKER-Stem-Cell-Cryopreservation-Solution.aspx or contact AMSBIO on +44-1235-828200 / +1-949-768-8365 or email info@amsbio.com.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognised today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development in the medical, nutrition, cosmetics and energy industries. The AMSBIO range includes specialist antibodies, peptides and recombinant proteins. In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as experts in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance screening outcomes and eventual prognosis. With a range of molecular detection reagents, and a significant Biorepository the company can also provide tissue DNA, RNA, protein and microarray products. Key research areas for these products include: Oncology, Regenerative Medicine, Environmental Analysis, Cytotoxicity Screening, Glycomics and Stem Cell Biology.
** STEM CELLBANKER is marketed as CELLBANKER 3 in Japan. AMSBIO is a global supplier of STEM-CELLBANKER® reagents.